| Micrus Endovascular to Present at CIBC World Markets 16th Annual Healthcare Conference on November 9 |
|
|
|
| Wednesday, 02 November 2005 | |
Micrus Endovascular to Present at CIBC World Markets 16th Annual Healthcare Conference on November 9SUNNYVALE, CA, (NAMC) - Micrus Endovascular Corporation (Nasdaq: MEND) today announced that John Kilcoyne, president and CEO, will make an investment community presentation at the CIBC World Markets 16th Annual Healthcare Conference on Wednesday, November 9 at 1:30 p.m. Eastern Time. A live audio webcast and slide presentation will be available via the Internet by visiting the Investor Relations section of the Micrus Web site at www.micruscorp.com. An archived presentation will be available on the Web site for 14 days. This conference will be held at The Waldorf-Astoria Hotel in New York. For more information about this conference visit http://conferences.cibcwm.com/health05/. About Micrus Endovascular Corporation Micrus Endovascular develops, manufactures and markets both implantable and disposable medical devices used in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists and neurosurgeons primarily to treat cerebral aneurysms responsible for hemorrhagic stroke, a significant cause of death in the United States. The Micrus product line enables physicians to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. Micrus' proprietary, three-dimensional microcoils are unique in that they automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells accessory devices and products used in conjunction with its microcoils. Contact: |
